Ending the Affordable Care Act’s cost-sharing subsidies would harm patients’ finances and health, trigger a “death spiral” in the health insurance exchanges, and force hospitals to shoulder an even greater financial burden, making it harder for them to serve their communities, the AHA, Federation of American Hospitals, The Catholic Health Association of the United States, and Association of American Medical Colleges said in a friend-of-the-court brief filed Saturday in State of California, et al., v. Donald J. Trump, et al. “All of this suggests that the cost-sharing subsidies provided for under the Act should continue to be made,” the brief states. “Congress meant for the Act to create exchanges where lower-income patients could purchase affordable insurance that they could actually use. Without the subsidy payments, government expenditures under the Act will increase, which would be in tension with the Act’s goals.” Filed by attorneys general in California and 18 other states, the lawsuit seeks to prevent the administration from ending the cost-sharing subsidy payments.

Related News Articles

News
The Centers for Medicare & Medicaid Services Feb. 9 released its 2027 proposed standards for the health insurance marketplaces, including the issuers and…
Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…
Headline
The Centers for Medicare & Medicaid Services Feb. 2 updated guidance originally issued in September on a budget reconciliation bill …
Headline
A KFF survey published today found that people view prior authorization as the biggest challenge beyond costs when navigating the health care system. In terms…
Headline
The Centers for Medicare & Medicaid Services Jan. 29 issued a final rule regarding states non-uniform or non-broad-based provider tax, as authorized under…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…